NFKB1 and cancer: Dr. Denis Guttridge (Medical University of South Carolina, South Carolina, United States), one of the two keynote speakers, highlighted an updated regulatory network of the NF-κB signaling as one of the key players in the skeletal muscle wasting during cancer cachexia.